Literature DB >> 1558155

Morphometric analysis of the actions of angiotensin II on renal arterioles and glomeruli.

K M Denton1, P A Fennessy, D Alcorn, W P Anderson.   

Abstract

To study the effects of angiotensin II on afferent and efferent arteriole diameters and on intraglomerular dimensions, angiotensin II (20 ng.kg-1.min-1) or saline vehicle was infused intravenously for 20 min into anesthetized rabbits pretreated with enalapril. Both kidneys were perfusion fixed (glutaraldehyde), and vascular casts were made of the right kidneys using methacrylate. Morphometric analysis of the left kidneys using transmission electron microscopy revealed no significant effects of angiotensin II within the glomerulus, including the degree of mesangial contraction. The diameters of the afferent and efferent arteriole casts from the right kidneys were measured at 20, 50, and 75 microns from the glomerulus by scanning electron microscopy. In the outer cortex the mean diameters of the afferent and efferent arterioles were 14.1 +/- 0.8 and 9.7 +/- 0.5 microns, respectively, in the angiotensin II-infused rabbits, significantly less than in the control (vehicle) rabbits, 17.0 +/- 0.7 microns (P less than 0.001) and 10.7 +/- 0.4 microns (P less than 0.005), respectively. Calculation of the relative changes in vascular resistance, however, indicated that the effects of angiotensin II on efferent arteriole resistance (average difference 2.4 +/- 1.2 units/microns) were significantly greater per unit length than the effects on afferent arteriole resistance (average difference 0.9 +/- 0.3 units/microns). Thus infused angiotensin II caused greater reduction in afferent arteriolar diameter than in efferent, but the calculated increase in vascular resistance per micron was greater in efferent vessels due to their smaller resting diameter.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1558155     DOI: 10.1152/ajprenal.1992.262.3.F367

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  15 in total

Review 1.  Glomerular Hyperfiltration in Diabetes: Mechanisms, Clinical Significance, and Treatment.

Authors:  Lennart Tonneijck; Marcel H A Muskiet; Mark M Smits; Erik J van Bommel; Hiddo J L Heerspink; Daniël H van Raalte; Jaap A Joles
Journal:  J Am Soc Nephrol       Date:  2017-01-31       Impact factor: 10.121

2.  Exogenous L-arginine does not affect angiotensin II-induced renal vasoconstriction in man.

Authors:  M Wolzt; A Ugurluoglu; L Schmetterer; G Dorner; G Zanaschka; C Mensik; H G Eichler
Journal:  Br J Clin Pharmacol       Date:  1998-01       Impact factor: 4.335

Review 3.  Structure and function of podocytes: an update.

Authors:  P Mundel; W Kriz
Journal:  Anat Embryol (Berl)       Date:  1995-11

4.  Angiotensin II depolarizes podocytes in the intact glomerulus of the Rat.

Authors:  J Gloy; A Henger; K G Fischer; R Nitschke; P Mundel; M Bleich; P Schollmeyer; R Greger; H Pavenstädt
Journal:  J Clin Invest       Date:  1997-06-01       Impact factor: 14.808

5.  Association of Acute Increases in Plasma Creatinine after Renin-Angiotensin Blockade with Subsequent Outcomes.

Authors:  Edouard L Fu; Marco Trevisan; Catherine M Clase; Marie Evans; Bengt Lindholm; Joris I Rotmans; Merel van Diepen; Friedo W Dekker; Juan-Jesus Carrero
Journal:  Clin J Am Soc Nephrol       Date:  2019-08-08       Impact factor: 8.237

6.  Blockade of myeloid differentiation 2 attenuates diabetic nephropathy by reducing activation of the renin-angiotensin system in mouse kidneys.

Authors:  Yi Wang; Qilu Fang; Yiyi Jin; Zhoudi Liu; Chunpeng Zou; Weihui Yu; Weixin Li; Xiaoou Shan; Ruijie Chen; Zia Khan; Guang Liang
Journal:  Br J Pharmacol       Date:  2019-05-23       Impact factor: 8.739

7.  Effect of exogenous and endogenous angiotensin II on intrarenal distribution of glomerular filtration rate in rats.

Authors:  Birte Treeck; Anca Beatrice Roald; Olav Tenstad; Knut Aukland
Journal:  J Physiol       Date:  2002-06-15       Impact factor: 5.182

Review 8.  Renal haemodynamic and protective effects of renoactive drugs in type 2 diabetes: Interaction with SGLT2 inhibitors.

Authors:  Rosalie A Scholtes; Michaël J B van Baar; Megan D Kok; Petter Bjornstad; David Z I Cherney; Jaap A Joles; Daniël H van Raalte
Journal:  Nephrology (Carlton)       Date:  2021-01-04       Impact factor: 2.506

9.  Contrast-induced nephropathy in interventional cardiology.

Authors:  Doron Sudarsky; Eugenia Nikolsky
Journal:  Int J Nephrol Renovasc Dis       Date:  2011-07-12

10.  Angiotensin II in experimental hyperdynamic sepsis.

Authors:  Li Wan; Christoph Langenberg; Rinaldo Bellomo; Clive N May
Journal:  Crit Care       Date:  2009-11-30       Impact factor: 9.097

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.